Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ferric Derisomaltose for Postoperative Anemia in Spinal Deformity Surgery
NCT05714007Phase 4Recruiting
- Sponsor
- Peking Union Medical College Hospital
- Start
- Aug 2023
- Primary completion
- Dec 2025
- Modality
- Inorganic Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ferric derisomaltose in postoperative anemia, sponsored by Peking Union Medical College Hospital. Started Aug 2023; status: recruiting.
02
Drugs
ferric derisomaltose
03
Conditions
postoperative anemia
Beyond the preview
Go deeper on NCT05714007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05714007.